ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2716

Support For Psychological State May Be Effective to Attain Remission Of Boolean-Based Definition Of Patient Global Assessment In Patients With Rheumatoid Arthritis

Mie Fusama1, Kumiko Yukioka2, Takanori Kuroiwa3, Chikako Yukioka4, Miyako Inoue2, Tae Nakanishi2, Norikazu Murata4, Noriko Takai5, Kayoko Higashi6, Taro Kuritani7, Keiji Maeda7, Yasushi Miura1, Hajime Sano8, Masao Yukioka4 and Hideko Nakahara9, 1Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Division of Clinical Psychology, Yukioka Hospital, Osaka, Japan, 3Department of Rheumatology, Yukioka Hospital, Osaka, Japan, 4Department of Orthopaedic Surgery, Yukioka Hospital, Osaka, Japan, 5Division of Clinical Psychology, Yukioka College of Health Science, Osaka, Japan, 6Division of nursing, NTT West Osaka Hospital, Osaka, Japan, 7Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan, 8Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya-city, Japan, 9Division of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Anxiety, depression, psychological status, quality of life and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Clinical Practice/Patient Care

Session Type: Abstract Submissions (ARHP)

Background/Purpose: The patients with rheumatoid arthritis (RA) often do not meet patient global assessment (PGA) remission criterion despite a good clinical disease state and, therefore, PGA is not solely influenced by RA disease activity.  It has been reported that PGA is a limiting factor for reaching remission.  We evaluated whether psychological state influences on Boolean-based definition of PGA remission for patients with RA.

Methods: The patients with RA (n=112) were recruited.  Disease activity was evaluated with swollen joint counts (SJC) and tender joint counts (TJC) and evaluator’s global assessment (EGA), PGA, and patient pain (Pain VAS) were assessed with visual analog scale.  Depression and anxiety were examined utilizing the Hospital Anxiety and Depression Scale-Depression (HADS-D) and the State-Trait Anxiety Inventory (STAI), respectively.  General health status was evaluated with Sort Form-36 (SF-36).  Comparison analyses were performed between remission group (VAS=<1cm) and non-remission group (VAS>1cm) in PGA, EGA, and pain VAS.  Data analyses were performed utilizing Wilcoxon rank-sum test and Spearman correlation analysis.

Results:  There was no significant difference in age, duration and PSL dosage between PGA remission group (n=35) and non-remission group (n=77) or EGA remission group (n=38) and non-remission group (n=74).  SJC and TJC of remission groups were significantly lower in PGA and EGA (p<0.0001, p<0.0001, respectively).  Among TJC, SJC and pain VAS, PGA was most significantly related to pain VAS (r=0.9232, p<0.0001), while EGA was related to SJC (r=0.7725, p<0.0001).  STAI (State) and HADS-D were significantly lower in pain VAS remission group (p=0.0018, p=0.0005, respectively).  STAI (State) was significantly lower in PGA remission group (p<0.05), while no significant difference was found between two groups in EGA (p=0.2463). Similarly in HADS-D, the number of patients with depression was significantly fewer in PGA remission group (p<0.05), while no significant difference was found between two groups in EGA (p=0.2522).  In SF-36, all of the eight components improved significantly in PGA remission group.  There was no significant difference in mental health between two groups in EGA (p=0.1602).  PGA is related to pain VAS, in contrast EGA is related to SJC.  The patients with pain VAS remission are less depressive and less anxious.  The patients with PGA remission have depression or anxiety less than those with PGA non-remission.  Moreover, mental health of SF-36 was significantly better in PGA remission group.  On the contrary, there is no significant difference in anxiety, depression and mental health of SF-36 between two groups in EGA.

Conclusion: Discrepancy between PGA and EGA, which is supposed to reflect disease activity of RA, may be partially explained by the difference in psychological state, and support for psychological state may be effective for improvement of PGA.  At present, clinical, radiological and functional remissions have been proposed as goal of treatment of RA.  As PGA remission is a limiting factor for Boolean remission and PGA relates to psychological state, psychological remission might be important to attain true remission.


Disclosure:

M. Fusama,
None;

K. Yukioka,
None;

T. Kuroiwa,
None;

C. Yukioka,
None;

M. Inoue,
None;

T. Nakanishi,
None;

N. Murata,
None;

N. Takai,
None;

K. Higashi,
None;

T. Kuritani,
None;

K. Maeda,
None;

Y. Miura,
None;

H. Sano,
None;

M. Yukioka,
None;

H. Nakahara,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/support-for-psychological-state-may-be-effective-to-attain-remission-of-boolean-based-definition-of-patient-global-assessment-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology